Literature DB >> 8300209

Regulation of Actinobacillus actinomycetemcomitans leukotoxin expression: analysis of the promoter regions of leukotoxic and minimally leukotoxic strains.

J M Brogan1, E T Lally, K Poulsen, M Kilian, D R Demuth.   

Abstract

The leukotoxin of Actinobacillus actinomycetemcomitans has been implicated as a virulence determinant in various human infections and is encoded by a multigene operon consisting of four known genes, designated ltxC, ltxA, ltxB, and ltxD. The ltx operon appears to be present in all A. actinomycetemcomitans strains, but levels of toxin expression vary greatly among strains. Thus, to gain a better understanding of the expression and regulation of the ltx operon, we have analyzed the ltx promoters of a highly toxic (JP2) and a minimally toxic (652) strain of A. actinomycetemcomitans. The nucleotide sequence of the JP2 ltx promoter contains -10 and -35 elements situated 350 bases upstream of ltxC, and primer extension of JP2 RNA confirmed that they are functional in vivo. However, a second primer extension product of 40 bases was present, and analysis of a series of truncated JP2 promoters fused to lacZ suggested that the region immediately upstream of ltxC also promotes transcription in Escherichia coli. These results suggest that two promoters may direct ltx expression in JP2. In addition, a small open reading frame capable of encoding a peptide of 78 amino acids was identified upstream of ltxC. Northern blots showed that this open reading frame is transcribed as part of a 4.2-kb mRNA, a transcript not previously identified as being derived from the ltx operon. In contrast, strain 652 expresses low steady-state levels of ltx mRNA, and its intact ltx promoter was inefficient in transcribing lacZ in E. coli. The nucleotide sequence of the 652 promoter is similar to that of the JP2 promoter but contains a region of 530 bp that is not present in JP2. Of 15 additional strains of A. actinomycetemcomitans that were analyzed, 13 contained promoters resembling the 652 sequence and 2 possessed JP2-like promoters. Both strains possessing the JP2-like promoter expressed 10- to 20-fold-higher levels of leukotoxin than did the strains possessing promoters resembling the 652 promoter. These results suggest that high levels of leukotoxin expression may correlate with the presence of the JP2-like promoter.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8300209      PMCID: PMC186135          DOI: 10.1128/iai.62.2.501-508.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Structure and function of the B and D genes of the Actinobacillus actinomycetemcomitans leukotoxin complex.

Authors:  E T Lally; E E Golub; I R Kieba; N S Taichman; S Decker; P Berthold; C W Gibson; D R Demuth; J Rosenbloom
Journal:  Microb Pathog       Date:  1991-08       Impact factor: 3.738

2.  Leukotoxic activity in different strains of the bacterium Actinobacillus actinomycetemcomitans isolated from juvenile periodontitis in man.

Authors:  P C Baehni; C C Tsai; W P McArthur; B F Hammond; B J Shenker; N S Taichman
Journal:  Arch Oral Biol       Date:  1981       Impact factor: 2.633

3.  Cytopathic effects of Actinobacillus actinomycetemcomitans on monkey blood leukocytes.

Authors:  N S Taichman; B J Shenker; C C Tsai; L T Glickman; P C Baehni; R Stevens; B F Hammond
Journal:  J Periodontal Res       Date:  1984-03       Impact factor: 4.419

4.  A comprehensive set of sequence analysis programs for the VAX.

Authors:  J Devereux; P Haeberli; O Smithies
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

5.  Infection due to Actinobacillus actinomycetemcomitans and Haemophilus aphrophilus.

Authors:  M I Page; E O King
Journal:  N Engl J Med       Date:  1966-07-28       Impact factor: 91.245

6.  Biochemical and morphological characterization of the killing of human monocytes by a leukotoxin derived from Actinobacillus actinomycetemcomitans.

Authors:  N S Taichman; R T Dean; C J Sanderson
Journal:  Infect Immun       Date:  1980-04       Impact factor: 3.441

7.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

Review 8.  Actinobacillus actinomycetemcomitans in human periodontal disease.

Authors:  J J Zambon
Journal:  J Clin Periodontol       Date:  1985-01       Impact factor: 8.728

9.  Serology of oral Actinobacillus actinomycetemcomitans and serotype distribution in human periodontal disease.

Authors:  J J Zambon; J Slots; R J Genco
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

10.  Complete nucleotide sequence of the E. coli glyA gene.

Authors:  M D Plamann; L T Stauffer; M L Urbanowski; G V Stauffer
Journal:  Nucleic Acids Res       Date:  1983-04-11       Impact factor: 16.971

View more
  91 in total

1.  Detection of cytolethal distending toxin activity and cdt genes in Actinobacillus actinomycetemcomitans isolates from geographically diverse populations.

Authors:  A S Fabris; J M DiRienzo; M Wïkstrom; M P A Mayer
Journal:  Oral Microbiol Immunol       Date:  2002-08

2.  Improved PCR for detection of the highly leukotoxic JP2 clone of Actinobacillus actinomycetemcomitans in subgingival plaque samples.

Authors:  Knud Poulsen; Oum-Keltoum Ennibi; Dorte Haubek
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

3.  Positive and negative cis-acting regulatory sequences control expression of leukotoxin in Actinobacillus actinomycetemcomitans 652.

Authors:  Christine Mitchell; Ling Gao; Donald R Demuth
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

4.  TdeA, a TolC-like protein required for toxin and drug export in Aggregatibacter (Actinobacillus) actinomycetemcomitans.

Authors:  Juan A Crosby; Scott C Kachlany
Journal:  Gene       Date:  2006-10-17       Impact factor: 3.688

5.  Abundant secretion of bioactive interleukin-1beta by human macrophages induced by Actinobacillus actinomycetemcomitans leukotoxin.

Authors:  P Kelk; R Claesson; L Hänström; U H Lerner; S Kalfas; A Johansson
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

6.  Novel loop-mediated isothermal amplification method for detection of the JP2 clone of Aggregatibacter actinomycetemcomitans in subgingival plaque.

Authors:  Mitsuko Seki; Knud Poulsen; Dorte Haubek; Mogens Kilian
Journal:  J Clin Microbiol       Date:  2007-12-26       Impact factor: 5.948

7.  Relationship between conversion of localized juvenile periodontitis-susceptible children from health to disease and Actinobacillus actinomycetemcomitans leukotoxin promoter structure.

Authors:  L C Bueno; M P Mayer; J M DiRienzo
Journal:  J Periodontol       Date:  1998-09       Impact factor: 6.993

8.  Leukotoxicity of Aggregatibacter actinomycetemcomitans in generalized aggressive periodontitis in Brazilians and their family members.

Authors:  Virginia Régia Souza Silveira; Márcia Viana Bessa Nogueira; Nádia Accioly Pinto Nogueira; Vilma Lima; Flávia Aparecida Chaves Furlaneto; Rodrigo Otávio Rego
Journal:  J Appl Oral Sci       Date:  2013 Sep-Oct       Impact factor: 2.698

Review 9.  Aggregatibacter actinomycetemcomitans leukotoxin: From mechanism to targeted anti-toxin therapeutics.

Authors:  Eric Krueger; Angela C Brown
Journal:  Mol Oral Microbiol       Date:  2020-03-10       Impact factor: 3.563

10.  Inhibition of P2X Receptors Protects Human Monocytes against Damage by Leukotoxin from Aggregatibacter actinomycetemcomitans and α-Hemolysin from Escherichia coli.

Authors:  Steen K Fagerberg; Martin R Jakobsen; Marianne Skals; Helle A Praetorius
Journal:  Infect Immun       Date:  2016-10-17       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.